CAST: Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke

Lancet

Volumn 349, Issue 9066, 1997, Pages 1641-1649

  Chen, Zheng Ming ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN TOMOGRAPHY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

EID: 0030985284     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)04010-5     Document Type: Article

References (28)

1. World Health Organization. World Health Statistics Annual, 1994. Geneva, Switzerland: World Health Organization; 1995.
2. Li SC, Schoenberg BS,Wang CC, Cheng XM, Bolis CL, Wang KJ. Cerebrovascular disease in the People's Republic of China: epidemiologic and clinical features. Neurology 1985; 35: 1708-13.
3. Chen DY, Wu GS, Wu CS, Hong SG, Zhang M, Zhao D. Incidence and diagnostic features of stroke in the Beijing MONICA population. Chinese Med J 1987; 7: 382-386.
4. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; ii: 349-60.
5. Antiplatelet Trialist' Collaboration. Collaborative overview of randomised trials of antiplatelet treatment. Part I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106.
6. Lindley RI, Amayo EO, Marshall J, Sandercock PAG, Dennis M, Warlow CP. Acute stroke treatment in UK hospitals: The Stroke Association Survey of consultant opinion. J R Coll Phys Lond 1995; 29: 4790-84.
7. Chen ZM, Sandercock P, Xie JX, Peto R, Collins R, Liu LS. Hospital management of acute ischaemic stroke in China. J Stroke Cerebrovasc Dis 1997; 6: 361-67.
8. Multicentre Acute Stroke Trial - Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet 1995; 346: 1509-14.
9. Counsell C, Sandercock P. The efficacy and safety of antiplatelet therapy in patients with acute presumed ischaemic stroke: a systematic review of the randomised trials comparing immediate antiplatelet therapy with control. In: Warlow C, Van Gijn J, Sandercock P (eds.) Stroke Module of The Cochrane Database of Systematic Reviews, [updated 02 December 1996]. Available in The Cochrane Library [disk and CDROM]. The Cochrane Collaboration; Issue 1. Oxford: Update Software; 1997.
10. Marsh EE, Adams HP, Biller J, Wasek P, Banwart K, Mitchell V, Woolson R. Use of antithrombotic drugs in the treatment of acute ischaemic stroke. A survey of neurologists in practice in the United States. Neurology 1989; 39: 1631-34.
11. Kent J, Bamford J. Consultant views on the use of aspirin in acute cerebrovascular disease: implications for clinical trials. Postgrad Med J 1994; 70: 185-87.
12. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997; 349: 1569-81.
13. Collins R, Doll R, Peto R. Ethics of clinical trials. In: Williams CJ, ed. Introducing new treatment for cancer: practical, ethical and legal problems. London: Wiley, 1992: 49-65.
14. Chen KJ, Chen K. Ischaemic stroke treated with Ligusticum chuanxiong. Chin Med J (English) 1992; 105: 870-873.
15. Chen ZM, Xie JX, Peto R, Collins R, Liu LS (for the CAST Collaborative Group). Chinese Acute Stroke Trial (CAST): Rationale, design and progress. Cerebrovasc Dis 1996; 6 (suppl 2): 23 (abstr).
16. Bamford JM, Sandercock PAG, Warlow CP, Slattery J. Inter-observer agreement for the asseeement of handicap in stroke patients. Stroke 1989; 20: 8.
17. Dennis M, Wellwood I, O'Rourke S, Machale S, Warlow C. How reliable are simple questions in assessing outcome after stroke? Cerebrovasc Dis 1997; 7: 19-21.
18. Peto R, Pike M, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient: I: introduction and design. Br J Cancer 1976; 34: 585-612.
19. Antiplatelet Trialist' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ 1988; 296: 320-331.
20. International Stroke Trial Collaborative Group. The International Stroke Trial. Preliminary results, Part I: Effects of aspirin and heparin separately and in combination. Cerebrovasc Dis 1996; 6 (suppl 2): 23 (abstr).
21. Bamford J, Dennis M, Sandercock P, Burn J, Warlow C. The frequency, causes and timing of death within 30 days of acute stroke: the Oxfordshire Community Stroke Project (OCSP). J Neurology Neurosurg Psychiatry 1990; 53: 824-29.
22. Huang CY, Chan FL, Yu YL, Woo E, Chin D. Cerebrovascular disease in Hong Kong Chinese. Stroke 1990; 21: 230-35.
23. Feldmann E, Daneault N, Kwan E, Ho KJ, Pessin MS, Langenberg P, Caplan LR. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 1990; 40: 1541-45.
24. Collins R, Peto R, Gray R, Parish S. Large-scale randomized evidence: trials and overviews. In: Weatherall D, Ledingham JGG, Warrell DA, eds. Oxford Textbook of Medicine, Volume 1. Oxford: Oxford University Press, 1996: 21-32.
25. Leon MB, Baim DS, Gordon P et al. Clinical and angiographic results from the Stent Anticoagulation Regimen Study (STARS). Circulation 1996; 94: I-685 (abstr).
26. Diener H, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurologi Sci 1996; 143: 1-13.
27. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-1339.
28. Born GVR, Collins R. Aspirin versus clopidogrel: the wrong question? Lancet 1997; 349: 806.